Kenneth Blum, Ph.D, MSc, BA (Pharmacy), DHL.

Editor-in-Chief
Department of Psychiatry, Western University College of Medicine, Pomona, CA, USA

Rajendra D. Badgaiyan, MD, MA (Psychology)

Co-Editor-in-Chief

Chief of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, San Antonio, TX, USA

Frequency: Bi-annual | ISSN: 2693-2180 | Previous Titles: Journal of Reward Deficiency Syndrome, Journal of Reward Deficiency Syndrome and Addiction Science

Abstracted/Indexed in: OCLC – WorldCat, SHERPA/RoMEO, Hinari, Genamics, J-Gate, Scilit and Google Scholar

016

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction

Kenneth Blum, Peter K. Thanos, Marlene Oscar-Berman, Marcelo Febo, David Baron, et al.
Recently there has been debate concerning the role of brain dopamine in reward and addiction. David Nutt and associates eloquently proposed that dopamine (DA) may be central to psycho stimulant dependence and some what important for alcohol, but not important for opiates, nicotine or even cannabis.

Read More

014

Designer Drugs: A Synthetic Catastrophe

James Fratantonio, Lawrence Andrade and Marcelo Febo
Synthetic stimulants can cause hallucinations, aggressive behaviors, death and are sometimes legal. These substances are sold as plant food and bath salts that are “Not for Human Consumption”, therefore skirting the 1986 Federal Analogue Act and giving a false pretense of safety.

Read More

008

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery

Kenneth Blum, Benjamin Thompson, Zsolt Demetrovics, John Femino, John Giordano, et al.
There are some who suggest that alcoholism and drug abuse are not diseases at all and that they are not consequences of a brain disorder as espoused recently by the American Society of Addiction Medicine (ASAM). Some would argue that addicts can quit on their own and moderate their alcohol and drug intake.

Read More

007

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity

Stephen J. Schoenthaler, Kenneth Blum, Eric R. Braverman, John Giordano, Ben Thompson, et al.
The connection between religion/spirituality and deviance, like substance abuse, was first made by Durkheim who defined socially expected behaviors as norms. He explained that deviance is due in large part to their absence (called anomie), and concluded that spirituality lowers deviance by preserving norms and social bonds.

Read More

006

Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis

Thomas McLaughlin, Kenneth Blum, Marlene Oscar-Berman, Marcelo Febo, Zsolt Demetrovics, et al
Lucid Dreams are a form of dream life, during which the dreamer may be aware that he/she is dreaming, can stop/re-start the dreams, depending on the pleasantness or unpleasant nature of the dream, and experiences the dream as if he/she were fully awake.

Read More

Welcome Note

It is a great pleasure to announce the inauguration of the first journal dedicated to the concept of Reward Deficiency Syndrome (RDS) coined in 1996 by one of us (KB) as a new way to look at all addictive, obsessive and compulsive behaviors including substance and process addictions, personality and spectrum disorders. The RDS concept embraced by the American Society of Addiction Medicine (ASAM) in the new definition of addiction has appeared in encyclopedias and has been used globally in hundreds of peer-reviewed articles.

Read More

Scope, Aims & Topics

Journal of Addiction Science (JAS) is a peer-reviewed quarterly published journal that promotes studies in the practice of addiction medicine and in clinical research, supporting addiction medicine as a mainstream medical sub-specialty. The Journal is published for physicians and other health professionals who need the most current news and information related to the treatment of addiction disorders information. All the published articles focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics

Read More